Polaryx Therapeutics, Inc. (PLYX)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
Aug 07, 16:00
2.25
-0.01
(-0.44%)
After-Hours: 19:59
Polaryx Therapeutics Market Cap : 107.00M for Aug. 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 07, 2026 | 107.00M |
| August 06, 2026 | 105.10M |
| August 05, 2026 | 106.05M |
| August 04, 2026 | 105.58M |
| August 03, 2026 | 103.68M |
| July 31, 2026 | 109.36M |
| July 30, 2026 | 101.79M |
| July 29, 2026 | 94.21M |
| July 28, 2026 | 94.21M |
| July 27, 2026 | 92.79M |
| July 24, 2026 | 97.05M |
| July 23, 2026 | 99.89M |
| July 22, 2026 | 106.05M |
| July 21, 2026 | 109.84M |
| July 20, 2026 | 107.00M |
| July 17, 2026 | 107.94M |
| July 16, 2026 | 109.36M |
| July 15, 2026 | 114.10M |
| July 14, 2026 | 107.00M |
| July 13, 2026 | 104.16M |
| July 10, 2026 | 110.31M |
| July 09, 2026 | 115.04M |
| July 08, 2026 | 120.73M |
| July 07, 2026 | 119.78M |
| July 06, 2026 | 125.46M |
| Date | Value |
|---|---|
| July 02, 2026 | 133.03M |
| July 01, 2026 | 122.15M |
| June 30, 2026 | 125.93M |
| June 29, 2026 | 119.78M |
| June 26, 2026 | 113.62M |
| June 25, 2026 | 109.36M |
| June 24, 2026 | 113.62M |
| June 23, 2026 | 114.10M |
| June 22, 2026 | 114.10M |
| June 18, 2026 | 109.84M |
| June 17, 2026 | 109.36M |
| June 16, 2026 | 108.42M |
| June 15, 2026 | 110.78M |
| June 12, 2026 | 112.20M |
| June 11, 2026 | 112.68M |
| June 10, 2026 | 107.00M |
| June 09, 2026 | 107.94M |
| June 08, 2026 | 116.46M |
| June 05, 2026 | 110.31M |
| June 04, 2026 | 119.78M |
| June 03, 2026 | 119.31M |
| June 02, 2026 | 124.99M |
| June 01, 2026 | 132.56M |
| May 29, 2026 | 154.81M |
| May 28, 2026 | 144.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 14.61M |
| CNBX Pharmaceuticals, Inc. | 0.214M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 571.38M |
| Fulcrum Therapeutics, Inc. | 296.75M |
Market Cap Related Metrics
| Price to Book Value | 43.01 |
| Price | 2.26 |
| Earnings Yield | -6.06% |